Medical test kits comprised principally of diagnostic reagents for medicinal use, diagnostic calibrators in the nature of myeloperoxidase in a buffer matrix for the measurement of MPO concentration in human plasma, and diagnostic reagents for medical use, specifically, for use as diagnostic controls in medical laboratories, all of the foregoing for the purpose of diagnosis and evaluation of patients at risk for adverse cardiac events